Disclosure Of Effect Of Changes In Foreign Exchange Rates [Text Block]

PCI Biotech Holding - Filing #5867918

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
Disclosure of effect of changes in foreign exchange rates [text block]
Foreign currency risk  
Disclosure of information when currency is not exchangeable into another currency [text block]
Disclosure of information when foreign operation’s functional currency is not exchangeable into presentation currency [text block]
Disclosure of summarised financial information about foreign operation [text block]
Disclosure of summarised financial information about foreign operation [abstract]
Disclosure of summarised financial information about foreign operation [line items]
Non-current assets
310,000 NOK
297,000 NOK
Current assets
30 905 NOK
43 753 NOK
Non-current liabilities
- NOK
34,000 NOK
Current liabilities
7 762 NOK
4 974 NOK
Profit (loss)
16 417 NOK
- NOK
16 417 NOK
- NOK
- NOK
20 315 NOK
20 315 NOK
- NOK
Other comprehensive income
- NOK
- NOK
- NOK
- NOK
- NOK
- NOK
- NOK
- NOK
Comprehensive income
16 417 NOK
- NOK
16 417 NOK
- NOK
- NOK
20 315 NOK
20 315 NOK
- NOK

Talk to a Data Expert

Have a question? We'll get back to you promptly.